Educated at esteemed institutions such as Dr. H.S. Gour University, Jadavpur University, Annamalai University, and the University of Westminster in London, she brings a multidisciplinary perspective to her research and professional work. Her work has focused on uncovering the therapeutic potential of bioactive compounds from traditional Indian medicine, with a rigorous approach to toxicity assessment and pharmacological profiling, aimed at developing safer and more effective therapeutic agents. Dr. Bigoniya has been a pioneer in exploring and characterizing the pharmacodynamic and pharmacokinetic properties of natural products. She has conducted studies on the bioavailability of active phytoconstituents, shedding light on how these compounds are absorbed, metabolized, and distributed in the body, and the resulting therapeutic impact. Her research has focused on the anti-inflammatory, antioxidant, and antidiabetic properties of plant-based compounds, using advanced methodologies such as LC/MS/MS for precise identification of bioactive molecules. With over 126 research publications in peer-reviewed journals and numerous presentations at national and international conferences, Dr. Bigoniya has significantly impacted both toxicology and achieving fellow status of the Academy of Toxicological Sciences (ATS). Her mentorship of graduate, postgraduate, and doctoral students ensures the continuation of high-quality research in toxicology and pharmacology, fostering new experts in these essential areas of pharmaceutical sciences. Dr. Bigoniya has also contributed to the development of standardized herbal formulations by following modern pharmacological protocols, as outlined in Ayurvedic monographs and international guidelines. Her projects on drug-food interactions in herbals provide valuable insights that support the safe integration of phytomedicines into clinical practice. Dr. Bigoniya’s expertise in toxicology includes conducting comprehensive preclinical toxicity studies to assess the safety profile of natural compounds, particularly from medicinal plants. Her research emphasizes hepatoprotective, nephroprotective, and cardioprotective effects, assessing the safety of phytoconstituents at cellular and systemic levels. Through her comprehensive approach to the safety and efficacy of phytoconstituents, she is contributing to the future of safer, evidence-based herbal therapeutics. Contributing as an expert peer reviewer for research projects of national and international significance, she has inculcated a strong background in pharmacology and toxicology, with a focus on developing safe and effective treatments for various health conditions. Dr. Bigoniya’s research has been recognized and supported by leading organizations, including AICTE, DRDE, MPCST, DST, UGC and NACO, demonstrating her impact on toxicology and pharmacology, particularly in the context of phytopharmacology. Dr. Papiya Bigoniya’s work has garnered national and international recognition through prestigious awards and accolades, reflecting her substantial contributions. Through her comprehensive approach to the safety and efficacy of phytoconstituents, she is contributing to the future of safer, evidence-based herbal therapeutics.